Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

4.44
Delayed Data
As of 3:59pm ET
 -0.05 / -1.11%
Today’s Change
4.08
Today|||52-Week Range
13.30
-22.38%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close4.49
Today’s open4.60
Day’s range4.44 - 4.60
Volume361,721
Average volume (3 months)1,115,113
Market cap$374.6M
Dividend yield--
Data as of 3:59pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)-154.67%
Earnings growth (this year)+22.97%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+25.59%
P/E ratioNM
Price/Sales2.40
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
CVRSCorindus Vascular Ro...-0.05-3.27%
SRDXSurModics Inc+0.15+0.50%
RMTIRockwell Medical Inc+0.01+0.15%
TIGTigenix NV+0.19+0.79%
Data as of 7:59pm ET, 09/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$192.9M
Annual profit (last year)-$154.7M
Net profit margin-80.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts